Clinical Trial Update: A Study of Concurrent Chemoradiation With Atezolizumab in Participants With Untreated Extensive-Stage (ES) Small Cell Lung Cancer (SCLC) [Phase 2]

View source ↗

Summary

Phase 2 study evaluating concurrent chemoradiation with atezolizumab in untreated extensive-stage small cell lung cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)

Snippet

Sponsor: Second Xiangya Hospital of Central South University | Conditions: Extensive-stage Small Cell Lung Cancer | Phase 2 | Status: COMPLETED